Pharmacogenomics die Zukunft ist jetzt
Roche paving the way for personalised medicine
The media briefing has taken place at Roche's headquarters in Basel on 20 June 2005.
Heino von Prondzynski, CEO Division Roche Diagnostics, Basel
Modern Diagnostics – paving the way for personalised medicine
Walter Koch, Vice President, Head of Research, Roche Molecular Diagnostics, Pleasanton
Pharmacogenomics – new tools for improved patient management: AmpliChip CYP450 and Leukemia tests
Prof. Torsten Haferlach, University Hospital Grosshadern, Munich
The impact of molecular profiling on care of patients with blood cancer
James L. Gallarda, Roche Molecular Diagnostics, Pleasanton
The importance of mutation analysis of the p53 tumor suppressor gene
Lyubomir Vassilev, Roche Pharmaceuticals, Nutley
Novel approach to cancer therapy